LeonaBio (LONA) Current Assets (2019 - 2026)

LeonaBio (LONA) has 8 years of Current Assets data on file, last reported at $69.2 million in Q1 2026.

• On a quarterly basis, Current Assets rose 73.64% year-over-year to $69.2 million in Q1 2026; TTM through Mar 2026 was $69.2 million, a 73.64% increase from a year earlier, with the FY2025 full-year figure at $89.5 million, up 63.12% from the prior year.
• Current Assets for Q1 2026 stood at $69.2 million, down from $89.5 million in the prior quarter.
• Over the last five years, Current Assets for LONA reached as high as $269.2 million in Q1 2022 and fell as low as $27.0 million in Q3 2025.
• Historically, Current Assets has averaged $135.9 million across 5 years, with a median of $128.6 million in 2024.
• Across the five-year window, Current Assets plunged 69.81% in 2025 and surged 73.64% in 2026, its largest moves.
• Year by year, Current Assets stood at $207.5 million in 2022, then retreated by 25.44% to $154.7 million in 2023, then slumped by 64.56% to $54.8 million in 2024, then surged by 63.12% to $89.5 million in 2025, then decreased by 22.64% to $69.2 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $69.2 million in Q1 2026, $89.5 million in Q4 2025, and $27.0 million in Q3 2025.